[1] Murray CJ, Ortblad KF, GuinoVart C, et al. Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013[J]. Lancet, 2014, 384(9947):1005-1070. [2] WHO. World Malaria Report 2015[R]. Geneva: World Health Organization, 2015. [3] Trager W, Jensen JB.Some recent advances in the cultivation of plasmodium falciparum[J]. Isr J Med Sci, 1978,14(5):563-570. [4] Geiman QM, Meagher MJ.Susceptibility of a New World monkey to plasmodium falciparum from man[J]. Nature,1967, 215(5099):437-439. [5] Trager W, Jensen JB.Human malaria parasites in continuous culture[J]. Science, 1976, 193(4254):673-675. [6] 杨恒林. 云南省疟疾防治研究概况[J].中国寄生虫病防治杂志, 2001, 14(1):54-56. [7] Fandeur T, Dubois P, Gysin J, et al.In vitro and in vivo studies on protective and inhibitory antibodies against plasmodium falciparum in the saimiri monkey[J]. J Immunol, 1984, 132(1):432-437. [8] 谢苑灵, 李娟兰, 龙祖培, 等. 体外培养的恶性疟原虫感染八种动物的观察[J]. 中国寄生虫学与寄生虫病杂志, 1987,5(3):238-238. [9] Ponnudurai T, Meuwissen JH, Leeuwenberg AD, et al.The production of mature gametocytes of plasmodium falciparumin continuous cultures of different isolates infective to mosquitoes[J]. Trans R Soc Trop Med Hyg,1982,76(2): 242-250. [10] Mesnil F, Roubaud E.Sur la senibilite du chimpanzee au paludisrne humaine[J]. C R Acad Sci,1917, 165:39-41. [11] Mesnil F, Roubaud E.Essais d'Inoculation du paludisme au chimpanzee[J]. Ann Inst Pasteur,1920, 34(7):466-480. [12] Rodhain J.Susceptibility of the chimpanzee to P. malariae of human origin[J]. Am J Trop Med Hyg,1948, 28(5):629-631. [13] Bray RS.Studies on malaria in chimpanzees V The sporogonous cycle and mosquito transmission of plasmodium vivax schwetzi[J]. J Parasitol, 1958, 44(1):46-51. [14] Rodhain J, Jadin J.The transmission of plasmodium falciparum in the splenectomized chimpanzee[J]. Ann Soc Belges Med Trop Parasitol Mycol, 1964, 44:531-535. [15] Cadigan FC, Iber PK, Chaicumpa V.Plasmodium falciparum in the white handed gibbon: Effect of prolonged infection on serum biochemistry values[J]. Proc Helminth Soc Washington, 1972, 39:28-33. [16] Ward RA, Morris JH, Gould DJ, et al.Susceptibility of the gibbon hylobateslar to falciparum malaria[J]. Science, 1965,150(3703):1604-1605. [17] Taliaferro WH, Taliaferro IG.The transmission of plasmodium falciparum to the Howlor monkey, Alouattasp.I. Generalnature of infection and morphology of the parasites[J]. Amer J Hyg, 1934, 19(2):318-334. [18] Young MD, Porter JA. Johnson CM.Plasmodium vivax transmitted from man to monkey to man[J]. Science, 1966,153(3739):1006-1007. [19] Gieman QM, Siddiqui WA, Schnell JV.Biological basis for susceptibility of aotus trivirgatus to species of plasmodia[J]. Mil Med, 1969, 134(10):780-786. [20] Hickman RL.The use of subhuman primate for experimental studies of human malaria[J]. Mil Med, 1969, 134(10):741-756. [21] Contaeos PG, Collisns WE.Faleiparum malaria transmissible from monkey to man by mosquito bite[J]. Science, 1969, 165(3896):918-919. [22] 江静波, 龙祖培, 周洁娴. 用换人血方法使恶性疟原虫 Plasmodium falciparum 在猕猴和熊猴体内转种传代的研究[J].中山大学学报:自然科学版, 1978, (4):6-16. [23] Gysin J, Aikawa M, Yourneur N, et al.Experimental plasmodium falciparum cerebral malaria in the squirrel monkey simiri sciureus[J]. Exp Parasitol, 1992, 75(4):390-398. [24] Tsuji M, Ishihara C, Arai S, et al.Establishment of a SCID mouse model having circulating human red blood cells and a possible growth of plasmodium falciparum in the mouse[J].Vaccine, 1995, 13(15): 1389-1392. [25] Moore JM, Kumar N, Shultz LD, et al.Maintenance of the human malarial parasite, plasmodium falciparum, in SCID mice and transmission of gametocytes to mosquitoes[J].J Exp Med,1995,181(6): 2265-2270. [26] Badell E, Oeuvray C, Moreno A, et al.Human malaria in immunocompromised mice: an in vivo model to study defense mechanisms against plasmodium falciparum[J]. J Exp Med, 2000, 192(11):1653-1660. [27] Farnert A, Snounou G, Rooth I, et al.Daily dynamics of plasmodium falciparum subpopulations in asymptomatic children in a holoendemic area[J]. Am J Trop Med Hyg, 1997, 56(5):538-547. [28] Moreno A, Sabater M, Moreno FJ, et al.Experimental infection of immunomodulated NOD LtSz-SCID mice as a new model for plasmodium falciparum erythrocytic stages[J]. Parasitol Res, 2005, 95(2):97-105. [29] Goonewardene R, Daily J, Kaslow D, et al.Transfection of the malaria parasites and exporession of firefiy luciferase[J]. Proc Nati Acad Sic U S A, 1993, 90(11):5234-9236. [30] Wu Y, Sifri CD, Lei HH, et al.Transfection of plasmodium falciparum within human red blood cell[J]. Proc Nati Acad Sic U S A, 1995, 92(4):973-977. [31] Van Dijk MR, Waters AP, Janse CJ, et al.Stable transfetion of malaria parasite blood stage[J]. Science, 1995, 268(5215):1358-1362. [32] Waters AP, Thomas AW, Van Dijk MR, et al.Transfection of malaria parasites[J]. Methods, 1997, 13(2):134-147. [33] Ménard R, Janse CJ.Gene targeting in malaria parasites. Methods[J], 1997, 13(2):148-157. [34] Gardner MJ, Hall N, Fung E, et al.Genome sequence of the human malaria parasite plasmodium falciparum[J]. Nature, 2002, 419(6906):498-511. [35] Crabb BS.Transfection technology and the study of drug resistance in the malaria parasite plasmodium falciparum[J]. Drug Resist Update, 2002, 5(3-4):126-130. [36] Horrocks P, Dechering K, Lanzer M.Control of gene expression in plasmodium falciparum[J]. Mol Biochem Parasitol, 1998, 95(2):171-181. [37] Fidock DA, Nomura T, Cooper RA, et al.Allelic modifications of the cg2 and cgl genes do not alter the chloroquine response of drug-resistant plasmodium falciparum[J]. Mol Biochem Parasitol, 2000, 110(1):1-10. [38] Sultan AA, Thathy V, Frevert U, et al.TRAP is necessary far gliding motility and infectivity of plasmodium sporozoites[J]. Cell, 1997, 90(3):511-522. [39] Crabb BS, Cooke BM, Reeder JC, et al.Targeted gene disruption show that knobs enable malaria-infected red cells to cytoadhere under physiological shear stress[J]. Cell, 1997,89(2):287-296. [40] Triglia T, Healer J, Caruana SR, et al.Apical membrane antigen 1 plays a central role in erythrocyte in vasion by plasmodium species[J]. Mol Microbiol, 2000, 38(4):706-718. [41] Baldi DL, Andrews KT, Waller RF, et al.RAP1 controls rhoptry targeting of RAP2 in the malaria parasite plasmodium falciparum[J]. EMBO J, 2000, 19(11):2435-2443. [42] Jansen R, Embden J, Gaastra W, et al.Identification of genes that are associated with DNA repeats in prokaryotes[J]. Molecular Microbiology, 2002, 43(6):1565-1575. [43] Sollelis L, Ghorbal M, Mac Pherson CR, et al.First efficient CRISPR-Cas9-mediated genome editing in leishmania parasites[J]. Cell Microbiol, 2015, 17(10):1405-1412. [44] Zhang WW, Matlashewski G.CRISPR-Cas9-mediated genome editing in leishmania donovani[J]. MBio, 2015, 6(4): e00861-15. [45] Wagner JC, Platt RJ, Goldfless SJ, et al.Efficient crispr-cas9-mediated genome editing in plasmodium falciparum[J]. Nature Methods, 2014, 11(9):915-918. [46] Kuang DX, Qiao JC, Zhou L, et al.Tag-in to endogenous genes of plasmodium falciparum using CRISPR/Cas9[J]. Parasit Vectors, 2017, 10(1):595-602. [47] Ariey F, Witkowski B, Amaratunga C, et al.A molecular marker of artemisinin-resistant plasmodium falciparum malaria[J]. Nature, 2014, 505(7481):50-55. [48] Ghorbal M, Gorman M, Macpherson CR, et al.Genome editing in the human malaria parasite plasmodium falciparum using the CRISPR-Cas9 system[J]. Nat Biotechnol, 2014, 32(8):819-821. [49] Ng CL, Siciliano G, Lee MC, et al.CRISPR-Cas9-modified pfmdr1 protects plasmodium falciparum asexual blood stages and gametocytes against a class of piperazine-containing compounds but potentiates artemisinin-based combination therapy partner drugs[J]. Mol Microbiol, 2016, 101(3):381-393. |